Company news

Share this article:
Eli Lilly announced a definitive agreement to acquire SGX Pharmaceuticals, a biotech specializing in oncology products, for $64 million, in an all-cash transaction.

Sudler & Hennessey announced the launch of 98.6°, a new patient health division. Jeanne Cloppse, managing director, will oversee the team. Areas of focus include disease state communications, treatment option and decisions, healthcare systems and the importance of compliance.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.